Monitor for: Gastrointestinal symptoms: Nausea or vomiting (occurring in approximately 1520% of patients at therapeutic doses per FDA labeling) Abdominal pain or cramping Diarrhea or constipation Loss of appetite or early satiety Bloating or abdominal distension Hypoglycemia indicators (particularly if you take other diabetes medications): Trembling, shakiness, or sweating Rapid heartbeat or palpitations Dizziness, lightheadedness, or confusion Hunger or irritability Headache or blurred vision Injection site reactions: Bruising, swelling, or hematoma formation Persistent pain or tenderness Redness or warmth suggesting inflammation Hardness or nodule formation under the skin Semaglutide's mechanism involves glucose-dependent insulin secretion, meaning hypoglycemia risk is generally low when used as monotherapy
doi: 10.1016/j.psyneuen.2021.105412
Whether youre in your 40s, 50s, or beyond, this guide is for you
At En Vogue IV Therapy & Wellness, our team is dedicated to helping you reach your weight loss goals in a safe, effective, and medically supervised manner
Conseils dutilisation 1 2 glules par jour avant le repas
Agents such as liraglutide (3.0 mg/day) [32] and semaglutide (2.4 mg/week) [28] have been shown to produce substantial weight loss in patients with or without diabetes
